PHASE 2A STUDY OF ALXN1007, A NOVEL C5A INHIBITOR, IN SUBJECTS WITH NEWLY DIAGNOSED ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) INVOLVING THE LOWER GASTROINTESTINAL TRACTA. M. Alousi, B. Yao, B. Overman, V. Ratanatharathorn,S. Gill, G. Socie, Y. Dai, S. Chasan-Taber, K. Anderson, A. Mujeebuddin,R. Champlin,E. Shpall, S. HoltanHAEMATOLOGICA（2016）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
